Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis (original) (raw)
Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression
Robert Simms
2009
View PDFchevron_right
Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis
Rong Xiao
Clinical epigenetics, 2014
View PDFchevron_right
Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis
László Czirják
Clinical immunology (Orlando, Fla.), 2017
View PDFchevron_right
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz
Frontiers in Immunology, 2018
View PDFchevron_right
CD8+ T cells in systemic sclerosis
Patrizia Fuschiotti
Immunologic Research, 2011
View PDFchevron_right
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea
Emiliano Antiga, Ilaria Pierini, S. Bellandi
British Journal of Dermatology, 2010
View PDFchevron_right
CD39 and control of cellular immune responses
Wenda Gao
Purinergic Signalling, 2007
View PDFchevron_right
Increased Expression of CD40 Ligand in Activated CD4 +T Lymphocytes of Systemic Sclerosis Patients
Annalisa Lamberti
Journal of …, 2000
View PDFchevron_right
CD38 in T- and B-Cell Functions
Francis Schuber, V. Berthelier, Philippe Deterre
Chemical Immunology and Allergy, 2000
View PDFchevron_right
Current perspectives on the role of CD8+ T cells in systemic sclerosis
Patrizia Fuschiotti
Immunology Letters, 2018
View PDFchevron_right
Down syndrome, autoimmunity and T regulatory cells
Roberto Accolla
Clinical and Experimental Immunology, 2012
View PDFchevron_right
Transforming growth factor-β increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis
Julie Baraut
Arthritis Research & Therapy, 2015
View PDFchevron_right
GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production
Patrizia Fuschiotti
Arthritis & Rheumatism, 2011
View PDFchevron_right
Short title: CD8 � downregulation in vivo
Akihiro Yachie
2002
View PDFchevron_right
Skin-resident effector memory CD8+CD28- T cells exhibit a pro-fibrotic phenotype in patients with systemic sclerosis
Patrizia Fuschiotti
The Journal of investigative dermatology, 2016
View PDFchevron_right
Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis
Patrizia Fuschiotti
Arthritis & Rheumatism, 2012
View PDFchevron_right
T lymphocyte abnormalities in juvenile systemic sclerosis patients
Bernadette Masinsin
Clinical Immunology, 2013
View PDFchevron_right
Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels
Raffaele Palma
Journal of Clinical Immunology, 2014
View PDFchevron_right
Decreased α/β Heterodimer among CD8 Molecules of Peripheral Blood T Cells in Wiskott–Aldrich Syndrome
Masayuki Nagasawa
Clinical Immunology and Immunopathology, 1996
View PDFchevron_right
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways
R. Visconti
View PDFchevron_right
Immunopathogenesis of Juvenile Systemic Sclerosis
Suzanne Li
Frontiers in Immunology, 2019
View PDFchevron_right
B regulatory cells are decreased and functionally impaired in patients with systemic sclerosis
Christos Liaskos
Arthritis & Rheumatology, 2015
View PDFchevron_right
Regulatory CD4 + CD25 high T cells, activated CD4 + CD25 high CD127 high T cells and multiple sclerosis
Jean-paul P Soulillou
Expert Review of Clinical Immunology, 2009
View PDFchevron_right
The magnitude of cytokine production by stimulated CD56(+) cells is associated with early stages of systemic sclerosis
Lorenzo Beretta
Clinical immunology (Orlando, Fla.), 2016
View PDFchevron_right
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation
Gabriele Valentini
2001
View PDFchevron_right
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin
Gabriele Valentini
Clinical and Experimental Immunology, 2006
View PDFchevron_right
a4b1 + and a4b7 + CD4 + T cell numbers increase and CLA + CD4 + T cell numbers decrease in systemic sclerosis
Roberto Paganelli
Clinical & Experimental Immunology, 2005
View PDFchevron_right
A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis
Athol Wells
International Journal of Immunogenetics, 2006
View PDFchevron_right
Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses
Gilles Marodon
Blood, 2005
View PDFchevron_right
14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T C 2 and CD8 + lymphocytes from patients with scleroderma
Christine Milcarek
The Journal of Allergy and Clinical Immunology, 2018
View PDFchevron_right
Primary T lymphocyte immunodeficiency associated with a selective impairment of CD2, CD3, CD43 (but not CD28)-mediated signal transduction
José Manzanares, Alfredo Corell
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Clonal CD8+ TCR-Vβ expanded populations with effector memory phenotype in Churg Strauss Syndrome
Alessandro Cignetti, Monica Boita, Sara Mariani, Paola Circosta, Antonella Vallario, Stefania Stella
Clinical Immunology, 2008
View PDFchevron_right
Cytokine mRNA Profile of Alveolar T Lymphocytes and Macrophages in Patients with Systemic Sclerosis Suggests a Local Tr1 Response
Lucia Mincheva-nilsson
Scandinavian Journal of Immunology, 2011
View PDFchevron_right
Regulatory functions of CD8+CD28– T cells in an autoimmune disease model
Samia Khoury
Journal of Clinical Investigation, 2003
View PDFchevron_right
CD38 expression on peripheral T and B Lymphocytes in newly diagnosed T1DM children Eman M. Saleh1 PhD, Nidhal abdul Mohymen2 PhD.
Nidhal A. A Mohammed
View PDFchevron_right